Every figure below is the company's own, as filed. Nothing is estimated and
nothing is smoothed — a period the filing does not support is left blank rather than
drawn.
Quarters are the company's own, counted from its financial
year ending 12-31.
Amounts in USD.
Revenue TTM
0
35M
70M
105M
Q3 '21: 73.9M
Q4 '21: 89.3M
Q1 '22: 90M
Q2 '22: 79.1M
Q3 '22: 70.7M
Q4 '22: 61.8M
Q1 '23: 57.7M
Q2 '23: 60.2M
Q3 '23: 64.3M
Q4 '23: 67.9M
Q1 '24: 70M
Q2 '24: 65.9M
Q3 '24: 58.4M
Q4 '24: 52.4M
Q1 '25: 46.7M
Q2 '25: 42.8M
Q3 '25: 40.1M
Q4 '25: 35.4M
Q1 '26: 29.3M
Q2 '26: 22.6M
Q4 '21
Q3 '22
Q2 '23
Q1 '24
Q4 '24
Q3 '25
Q2 '26
Gross Profit TTM
0
30M
60M
90M
Q4 '21: 80.3M
Q1 '22: 82M
Q2 '22: 71.5M
Q3 '22: 63.1M
Q4 '22: 53.6M
Q1 '23: 49.4M
Q2 '23: 51.2M
Q3 '23: 54.3M
Q4 '23: 57.2M
Q1 '24: 59M
Q2 '24: 56.2M
Q3 '24: 50.6M
Q4 '24: 46.3M
Q1 '25: 41.3M
Q2 '25: 37.3M
Q3 '25: 33.7M
Q4 '25: 28.2M
Q1 '26: 22.3M
Q2 '26: 16.6M
Q4 '21
Q3 '22
Q2 '23
Q1 '24
Q4 '24
Q3 '25
Q2 '26
Revenue minus cost of sales. This filer tags no gross profit of its own..
Operating Income TTM
-45M
-30M
-15M
0
15M
30M
45M
Q3 '21: -30.4M
Q4 '21: -23.5M
Q1 '22: -24.1M
Q2 '22: -33M
Q3 '22: 11.7M
Q4 '22: -8.6M
Q1 '23: -12.5M
Q2 '23: -12.9M
Q3 '23: -11.2M
Q4 '23: 4.6M
Q1 '24: 6.1M
Q2 '24: 5.3M
Q3 '24: 2.4M
Q4 '24: 1.7M
Q1 '25: -588.8K
Q2 '25: -610.3K
Q3 '25: -949.6K
Q4 '25: -7.8M
Q1 '26: -10.2M
Q2 '26: -12.7M
Q4 '21
Q3 '22
Q2 '23
Q1 '24
Q4 '24
Q3 '25
Q2 '26
Net Income TTM
-45M
-30M
-15M
0
15M
30M
45M
Q3 '20: -22.6M
Q4 '20: -17.1M
Q1 '21: 565.8K
Q2 '21: 14.3M
Q3 '21: -27.8M
Q4 '21: -24.2M
Q1 '22: -26.8M
Q2 '22: -35.7M
Q3 '22: 7.2M
Q4 '22: -12.9M
Q1 '23: -14.9M
Q2 '23: -14.2M
Q3 '23: -11.8M
Q4 '24: 1.2M
Q1 '25: -1.2M
Q2 '25: -1.3M
Q3 '25: -1.3M
Q4 '25: -8.9M
Q1 '26: -12.1M
Q2 '26: -15.8M
Q4 '20
Q3 '21
Q2 '22
Q1 '23
Q4 '24
Q3 '25
Q2 '26
Cost of Revenue TTM
0
4M
8M
12M
Q3 '21: 9.2M
Q4 '21: 9M
Q1 '22: 7.9M
Q2 '22: 7.6M
Q3 '22: 7.7M
Q4 '22: 8.2M
Q1 '23: 8.3M
Q2 '23: 9M
Q3 '23: 10M
Q4 '23: 10.7M
Q1 '24: 11M
Q2 '24: 9.7M
Q3 '24: 7.8M
Q4 '24: 6.1M
Q1 '25: 5.5M
Q2 '25: 5.6M
Q3 '25: 6.5M
Q4 '25: 7.2M
Q1 '26: 7M
Q2 '26: 6M
Q4 '21
Q3 '22
Q2 '23
Q1 '24
Q4 '24
Q3 '25
Q2 '26
Operating Cash Flow TTM
-15M
0
15M
30M
45M
Q3 '21: 21M
Q4 '21: 33M
Q1 '22: 31.7M
Q2 '22: 25.4M
Q3 '22: 20.3M
Q4 '22: 9.4M
Q1 '23: 4.9M
Q2 '23: 8.9M
Q3 '23: 7.8M
Q4 '23: 6.1M
Q1 '24: 11.3M
Q2 '24: 12.4M
Q3 '24: 13.3M
Q4 '24: 14M
Q1 '25: 5.8M
Q2 '25: 11.1K
Q3 '25: -2.1M
Q4 '25: -3.7M
Q1 '26: -3.1M
Q2 '26: -5.6M
Q4 '21
Q3 '22
Q2 '23
Q1 '24
Q4 '24
Q3 '25
Q2 '26
Free Cash Flow TTM
-15M
0
15M
30M
45M
Q3 '21: 18.9M
Q4 '21: 30.3M
Q1 '22: 23.7M
Q2 '22: 12.2M
Q3 '22: 3.9M
Q4 '22: -5.9M
Q1 '23: -5M
Q2 '23: 2.4M
Q3 '23: 5.3M
Q4 '23: 3.5M
Q1 '24: 9.3M
Q2 '24: 12.2M
Q3 '24: 13.2M
Q4 '24: 13.5M
Q1 '25: 5M
Q2 '25: -586.4K
Q3 '25: -3.1M
Q4 '25: -4.2M
Q1 '26: -3.4M
Q2 '26: -6.1M
Q4 '21
Q3 '22
Q2 '23
Q1 '24
Q4 '24
Q3 '25
Q2 '26
Operating cash flow minus capital expenditure.
Shares Outstanding Quarterly
0
1.5B
3B
4.5B
Q4 '15: 21.2M
Q2 '20: 3.2B
Q3 '20: 3B
Q1 '21: 3.7B
Q2 '21: 3.5B
Q3 '21: 3B
Q1 '22: 3.8B
Q2 '22: 2.7B
Q3 '22: 2.6B
Q1 '23: 3.7B
Q2 '23: 3.7B
Q3 '23: 3.7B
Q1 '24: 3.1B
Q2 '24: 2.9B
Q3 '24: 1.9B
Q1 '25: 1.9B
Q2 '25: 2.9B
Q3 '25: 1.9B
Q1 '26: 1.8B
Q2 '26: 1.8B
Q2 '20
Q2 '21
Q2 '22
Q2 '23
Q2 '24
Q2 '25
Q2 '26
Weighted average diluted, as the filer reports it for each period. An average cannot be added across periods, so this one is always shown per period the filer tagged rather than as a trailing year.
EPS TTM
-0.01
-0.01
-0.00
0.00
0.00
0.01
0.01
Q2 '21: 0.00
Q3 '21: -0.01
Q4 '21: -0.01
Q1 '22: -0.01
Q2 '22: -0.01
Q3 '22: 0.00
Q4 '22: -0.01
Q1 '23: -0.01
Q2 '23: -0.01
Q3 '23: -0.01
Q4 '23: 0.00
Q1 '24: 0.00
Q2 '24: 0.00
Q3 '24: 0.00
Q4 '24: 0.00
Q1 '25: 0.00
Q2 '25: 0.00
Q3 '25: 0.00
Q4 '25: -0.01
Q1 '26: -0.01
Q3 '21
Q2 '22
Q1 '23
Q4 '23
Q3 '24
Q2 '25
Q1 '26
The filer's own published earnings a share for each quarter, four quarters added up. The company page divides trailing net income by the share count instead, which lands within about 1% of this and is not the same sum, so the two are named differently rather than presented as one figure.